{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T21:41:30Z","timestamp":1776807690956,"version":"3.51.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Ferroptosis is a type of iron-dependent necrosis related to cancer. Nevertheless, the features of ferroptosis in gastric cancer (GC) remain poorly understood. This study conducted a systematic analysis of ferroptosis regulators in GC.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We gathered five GC cohorts, namely, TCGA-STAD, GSE84437, GSE62254, GSE26901, and GSE15459. Unsupervised clustering analysis was adopted to cluster GC patients into different ferroptosis subtypes based on ferroptosis regulators. Immune cell infiltration and hallmark pathway activity were estimated <jats:italic>via<\/jats:italic> ssGSEA. The ferroptosis index was developed with the PCA computational method. Response to chemotherapy agents and small molecular compounds was inferred <jats:italic>via<\/jats:italic> GDSC, CTRP, and PRISM projects. Two anti-PD-1 therapy cohorts were gathered and the potential of FPI in predicting immune response was assessed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Expression profiles, genetic mutations, DNA methylation, prognostic implications, and drug sensitivity of ferroptosis regulators were characterized in GC. Three ferroptosis subtypes were clustered with distinct prognosis, hallmark pathway activity, and tumor-infiltrating immune cells. Ferroptosis levels were quantified based on the expression of prognostic ferroptosis-related signatures. The significant relationships between FPI and clinicopathological characteristics were observed. Furthermore, high FPI was in relation to poor prognosis, inflamed tumor microenvironment (TME) as well as high sensitivity to chemotherapy agents (docetaxel and cisplatin), and CTRP- and PRISM-derived compounds. Also, FPI acted as a promising predictor of immune response.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Collectively, our findings identified a novel ferroptosis-based subtype classification of GC, and revealed the potential of ferroptosis in forming TME diversity and complexity, and guiding individualized treatment.<\/jats:p>","DOI":"10.3389\/fphar.2022.919490","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T07:26:03Z","timestamp":1657610763000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Comprehensive Analysis of the Aberrance and Functional Significance of Ferroptosis in Gastric Cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Jun","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbrc.2021.08.080","article-title":"SIRT6 Silencing Overcomes Resistance to Sorafenib by Promoting Ferroptosis in Gastric Cancer","volume":"577","author":"Cai","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.23750\/abm.v89i8-S.7966","article-title":"Epidemiology of Gastric Cancer and Risk Factors","volume":"89","author":"Cavatorta","year":"2018","journal-title":"Acta Biomed."},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2105-12-35","article-title":"VennDiagram: a Package for the Generation of Highly-Customizable Venn and Euler Diagrams in R","volume":"12","author":"Chen","year":"2011","journal-title":"BMC Bioinforma."},{"key":"B6","doi-asserted-by":"publisher","first-page":"739039","DOI":"10.3389\/fimmu.2021.739039","article-title":"Characterization of Interplay between Autophagy and Ferroptosis and Their Synergistical Roles on Manipulating Immunological Tumor Microenvironment in Squamous Cell Carcinomas","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor Package for Integrative Analysis of TCGA Data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular Analysis of Gastric Cancer Identifies Subtypes Associated with Distinct Clinical Outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","article-title":"Lumi: a Pipeline for Processing Illumina Microarray","volume":"24","author":"Du","year":"2008","journal-title":"Bioinformatics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the Crossroads of Cancer-Acquired Drug Resistance and Immune Evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s11658-021-00271-y","article-title":"Induction of Ferroptosis by ATF3 Elevation Alleviates Cisplatin Resistance in Gastric Cancer by Restraining Nrf2\/Keap1\/xCT Signaling","volume":"26","author":"Fu","year":"2021","journal-title":"Cell Mol. Biol. Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy--Analysis of Affymetrix GeneChip Data at the Probe Level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","article-title":"Next-generation Characterization of the Cancer Cell Line Encyclopedia","volume":"569","author":"Ghandi","year":"2019","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"BSR20201807","DOI":"10.1042\/bsr20201807","article-title":"Tanshinone IIA Induces Ferroptosis in Gastric Cancer Cells through P53-Mediated SLC7A11 Down-Regulation","volume":"40","author":"Guan","year":"2020","journal-title":"Biosci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: Gene Set Variation Analysis for Microarray and RNA-Seq Data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T Cell Dysfunction and Exclusion Predict Cancer Immunotherapy Response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"32433","DOI":"10.1073\/pnas.2006828117","article-title":"Polyunsaturated Fatty Acid Biosynthesis Pathway Determines Ferroptosis Sensitivity in Gastric Cancer","volume":"117","author":"Lee","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The Sva Package for Removing Batch Effects and Other Unwanted Variation in High-Throughput Experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1053\/j.gastro.2013.05.010","article-title":"Identification of Molecular Subtypes of Gastric Cancer with Different Responses to PI3-Kinase Inhibitors and 5-fluorouracil","volume":"145","author":"Lei","year":"2013","journal-title":"Gastroenterology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) Hallmark Gene Set Collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","article-title":"Integrative Molecular and Clinical Modeling of Clinical Outcomes to PD1 Blockade in Patients with Metastatic Melanoma","volume":"25","author":"Liu","year":"2019","journal-title":"Nat. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.apsb.2021.05.006","article-title":"Identification of Ferroptosis as a Novel Mechanism for Antitumor Activity of Natural Product Derivative A2 in Gastric Cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"B25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 Attenuates Tumour Response to PD-L1 Blockade by Contributing to Exclusion of T Cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: Efficient and Comprehensive Analysis of Somatic Variants in Cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13287-021-02394-7","article-title":"MiR-375 Reduces the Stemness of Gastric Cancer Cells through Triggering Ferroptosis","volume":"12","author":"Ni","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.03.009","article-title":"Ferroptosis, Necroptosis, and Pyroptosis in the Tumor Microenvironment: Perspectives for Immunotherapy of SCLC","author":"Niu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41467-018-04179-8","article-title":"Clinical and Genomic Landscape of Gastric Cancer with a Mesenchymal Phenotype","volume":"9","author":"Oh","year":"2018","journal-title":"Nat. Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4251\/wjgo.v12.i8.857","article-title":"Identification of an Immune-Related Gene-Based Signature to Predict Prognosis of Patients with Gastric Cancer","volume":"12","author":"Qiu","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma Powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/s0140-6736(16)00561-4","article-title":"Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed Following Treatment with Platinum-Based Chemotherapy: a Single-Arm, Multicentre, Phase 2 Trial","volume":"387","author":"Rosenberg","year":"2016","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","article-title":"Tumor Immune Microenvironment Characterization in Clear Cell Renal Cell Carcinoma Identifies Prognostic and Immunotherapeutically Relevant Messenger RNA Signatures","volume":"17","author":"\u015eenbabao\u011flu","year":"2016","journal-title":"Genome Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jtho.2016.06.019","article-title":"Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma","volume":"11","author":"Shao","year":"2016","journal-title":"J. Thorac. Oncol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1158\/1078-0432.Ccr-16-2211","article-title":"Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by the Cancer Genome Atlas Project","volume":"23","author":"Sohn","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","article-title":"Ferroptosis, Necroptosis, and Pyroptosis in Anticancer Immunity","volume":"13","author":"Tang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T Cells Regulate Tumour Ferroptosis during Cancer Immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1111\/jcmm.16217","article-title":"Piezo Type Mechanosensitive Ion Channel Component 1 Facilitates Gastric Cancer Omentum Metastasis","volume":"25","author":"Wang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a Class Discovery Tool with Confidence Assessments and Item Tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a Resource for Therapeutic Biomarker Discovery in Cancer Cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12885-020-06814-4","article-title":"Deconvolution of Diffuse Gastric Cancer and the Suppression of CD34 on the BALB\/c Nude Mice Model","volume":"20","author":"Yoon","year":"2020","journal-title":"BMC Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2105-14-244","article-title":"RCircos: an R Package for Circos 2D Track Plots","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Bioinforma."},{"key":"B45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-020-01168-8","article-title":"CAF Secreted miR-522 Suppresses Ferroptosis and Promotes Acquired Chemo-Resistance in Gastric Cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10120-018-0813-2","article-title":"The Efficacy and Safety of Targeted Therapy with or without Chemotherapy in Advanced Gastric Cancer Treatment: a Network Meta-Analysis of Well-Designed Randomized Controlled Trials","volume":"21","author":"Zhao","year":"2018","journal-title":"Gastric Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3389\/fonc.2019.01398","article-title":"Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer","volume":"9","author":"Zhou","year":"2019","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.919490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T07:26:07Z","timestamp":1657610767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.919490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":47,"alternative-id":["10.3389\/fphar.2022.919490"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.919490","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]},"article-number":"919490"}}